What we do Deep Diamond India Ltd manufactures and wholesales gold diamond-studded jewellery and provides pharmaceutical consultancy and drug marketing services with a focus on innovative therapies. |
Founded in 1,994 |
Market share Emerging player in pharmaceutical consultancy; maintains legacy jewellery segment with evolving product diversification. |
Problem solved Addresses demand for quality diamond jewellery and offers pharma consultancy to optimize drug delivery, patient support, and supply chain management. |
Top clients or who we serve Serves end consumers for jewellery and healthcare providers, patients, and hospitals in pharmaceuticals; B2B and B2C segments. |
Key management Mr. Narayan Singh Rathore (Managing Director), Mrs. Laveena Pokharna (Whole Time Director & CFO), Mr. Rajesh Pherwani (Whole Time Director & CEO) |
Our journey and innovations Since 1994 in jewellery, diversified into pharmaceuticals by 2023, acquired Microcure Biotech as subsidiary in 2025, and recently listed on BSE. |
Where we operate India with strong presence in Mumbai; expanding pharmaceutical services nationally. |
Top products or what we offer Gold diamond jewellery, loose diamonds, solitaires; pharmaceutical consultancy, drug marketing, patient support services. |
Top brands - |
Raw materials needed Gold, diamonds for jewellery segment; raw materials for pharmaceutical products sourced via partners. |
Raw materials supplier - |
Recurring vs cyclical contribution Pharmaceutical consultancy delivers higher margin and recurring revenues; jewellery segment sees cyclical demand. |
Our industry position Niche supplier in pharma consultancy and evolving presence in jewellery retail market. |
Financial highlights FY 2025 revenue INR 1.26 crore; profit after tax INR 0.88 crore, showing moderate growth compared to previous year. |
Geographical revenue split - |
Order book - |
Whats driving growth Diversification into pharmaceuticals, strategic acquisitions, professional management, and increasing consultancy services. |
Our future plans Expand pharmaceutical product portfolio, increase market penetration, and enhance service offerings. |
Our green promise - |
Our people and values Small dedicated team fostering innovation, ethical standards, and customer-centric approach. |
Key challenges ahead Competitive pharmaceutical market and maintaining growth in traditional jewellery business. |
Interesting facts Transitioned from a legacy jewellery company to a diversified pharmaceutical consultancy and biotechnology player. |
Risks and strategy Mitigates competitive risks through acquisitions, compliance, and expanding service offerings. |
